| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | PALISADE BIO, INC. | 486,914 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-13 | Lind Global Fund II LP | PALISADE BIO, INC. | 158,355 | - | EDGAR |
| SC 13G/A | 2024-02-09 | L1 Capital Global Opportunities Master Fund, Ltd. | PALISADE BIO, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-06 | INTRACOASTAL CAPITAL, LLC | PALISADE BIO, INC. | 180,532 | 1.9% | EDGAR |
| SC 13G | 2023-09-15 | Lind Global Fund II LP | PALISADE BIO, INC. | 743,313 | - | EDGAR |
| SC 13G | 2023-09-15 | L1 Capital Global Opportunities Master Fund, Ltd. | PALISADE BIO, INC. | 584,958 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Altium Capital Management LP | PALISADE BIO, INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | PALISADE BIO, INC. | 281,054 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-13 | Lind Global Fund II LP | PALISADE BIO, INC. | 30,987 | - | EDGAR |
| SC 13G/A | 2023-02-08 | INTRACOASTAL CAPITAL, LLC | PALISADE BIO, INC. | 131,086 | 5.7% | EDGAR |
| SC 13G | 2022-08-22 | INTRACOASTAL CAPITAL, LLC | PALISADE BIO, INC. | 7,602,862 | 10.0% | EDGAR |
| SC 13G | 2022-08-18 | Lind Global Fund II LP | PALISADE BIO, INC. | 4,000,000 | - | EDGAR |
| SC 13G/A | 2022-02-14 | Altium Capital Management LP | PALISADE BIO, INC. | 333,954 | 5.0% | EDGAR |
| SC 13G | 2022-02-14 | Altium Capital Management LP | PALISADE BIO, INC. | 271,303 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-11 | INTRACOASTAL CAPITAL, LLC | PALISADE BIO, INC. | 196,142 | 1.4% | EDGAR |
| SC 13D | 2021-08-30 | Yuma Regional Medical Center | PALISADE BIO, INC. | 2,247,452 | 19.0% | EDGAR |
| SC 13G | 2021-05-11 | Altium Capital Management LP | PALISADE BIO, INC. | 1,107,557 | 9.8% | EDGAR |
| SC 13G/A | 2021-02-11 | RENAISSANCE TECHNOLOGIES LLC | Seneca Biopharma, Inc. | 167,512 | 1.0% | EDGAR |
| SC 13G/A | 2021-02-11 | Hudson Bay Capital Management LP | Seneca Biopharma, Inc. | 857,985 | 4.7% | EDGAR |
| SC 13G/A | 2021-01-29 | INTRACOASTAL CAPITAL, LLC | Seneca Biopharma, Inc. | 1,176,852 | 6.4% | EDGAR |